The DOI matches its Crossref record; 35 of the 35 references it cites were found in a registry or an index.
Antiviral therapy in chronic hepatitis B viral infection during pregnancy: A systematic review and meta‐analysis
Open accessAbstract
Perinatal or mother‐to‐child transmission (MTCT) of hepatitis B virus (HBV) remains the major risk factor for chronic HBV infection worldwide. In addition to hepatitis B immune globulin and vaccination, oral antiviral therapies in highly viremic mothers can further decrease MTCT of HBV. We conducted a systematic review and meta‐analysis to synthesize the evidence on the efficacy and maternal and fetal safety of antiviral therapy during pregnancy. A protocol was developed by the American Association for the Study of Liver Diseases guideline writing committee. We searched multiple databases for controlled studies that enrolled pregnant women with chronic HBV infection treated with antiviral therapy. Outcomes of interest were reduction of MTCT and adverse outcomes to mothers and newborns. Study selection and data extraction were done by pairs of independent reviewers. We included 26 studies that enrolled 3622 pregnant women. Antiviral therapy reduced MTCT, as defined by infant hepatitis B surface antigen seropositivity (risk ratio = 0.3, 95% confidence interval 0.2‐0.4) or infant HBV DNA seropositivity (risk ratio = 0.3, 95% confidence interval 0.2‐0.5) at 6‐12 months. No significant differences were found in the congenital malformation rate, prematurity rate, and Apgar scores. Compared to control, lamivudine or telbivudine improved maternal HBV DNA suppression at delivery and during 4‐8 weeks' postpartum follow‐up. Tenofovir showed improvement in HBV DNA suppression at delivery. No significant differences were found in postpartum hemorrhage, cesarean section, and elevated creatinine kinase rates. Conclusions: Antiviral therapy improves HBV suppression and reduces MTCT in women with chronic HBV infection with high viral load compared to the use of hepatitis B immunoglobulin and vaccination alone; the use of telbivudine, lamivudine, and tenofovir appears to be safe in pregnancy with no increased adverse maternal or fetal outcome. (H epatology 2016;63:319–333)
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Preferred Reporting Items for Systematic Reviews and Meta-Analyses: the PRISMA statement
Moher, D., Liberati, A., Tetzlaff, J., Altman, D. G., & for the PRISMA Group (2009) · BMJ · doi:10.1136/bmj.b2535 · Cited by 83,823
Preferred reporting items for systematic reviews and meta-analyses: The PRISMA statement
Moher, D., Liberati, A., Tetzlaff, J., Altman, D. G., & the PRISMA Group* (2009) · Annals of Internal Medicine · doi:10.7326/0003-4819-151-4-200908180-00135 · Cited by 37,554
Sterne, J. A. C., Sutton, A. J., Ioannidis, J. P. A., Terrin, N., Jones, D. R., Lau, J., Carpenter, J., Rucker, G., Harbord, R. M., Schmid, C. H., et al. (2011) · BMJ · doi:10.1136/bmj.d4002 · Cited by 7,709
Chronic hepatitis B: Update 2009 #
Lok, A. S. F., & McMahon, B. J. (2009) · Hepatology · doi:10.1002/hep.23190 · Cited by 2,831
Self-citationAASLD guidelines for treatment of chronic hepatitis B
Terrault, N. A., Bzowej, N. H., Chang, K., Hwang, J. P., Jonas, M. M., & Murad, M. H. (2016) · Hepatology · doi:10.1002/hep.28156 · Cited by 2,006
Self-citationVertical Transmission of Hepatitis B Antigen in Taiwan
Stevens, C. E., Beasley, R. P., Tsui, J., & Lee, W.-C. (1975) · New England Journal of Medicine · doi:10.1056/nejm197504102921503 · Cited by 1,022
Chang, T.-T., Liaw, Y.-F., Wu, S.-S., Schiff, E., Han, K.-H., Lai, C.-L., Safadi, R., Lee, S. S., Halota, W., Goodman, Z., et al. (2010) · Hepatology · doi:10.1002/hep.23785 · Cited by 972
Long-term Therapy With Adefovir Dipivoxil for HBeAg-Negative Chronic Hepatitis B for up to 5 Years
Hadziyannis, S. J., Tassopoulos, N. C., Heathcote, E. J., Chang, T., Kitis, G., Rizzetto, M., Marcellin, P., Lim, S. G., Goodman, Z., Ma, J., et al. (2006) · Gastroenterology · doi:10.1053/j.gastro.2006.09.020 · Cited by 881
Tenney, D. J., Rose, R. E., Baldick, C. J., Pokornowski, K. A., Eggers, B. J., Fang, J., Wichroski, M. J., Xu, D., Yang, J., Wilber, R. B., et al. (2009) · Hepatology · doi:10.1002/hep.22841 · Cited by 804
Long-term safety of lamivudine treatment in patients with chronic hepatitis B
Lok, A. S. F., Lai, C.-L., Leung, N., Yao, G.-B., Cui, Z.-Y., Schiff, E. R., Dienstag, J. L., Heathcote, E. J., Little, N. R., Griffiths, D. A., et al. (2003) · Gastroenterology · doi:10.1053/j.gastro.2003.09.033 · Cited by 764
Self-citationThree-Year Efficacy and Safety of Tenofovir Disoproxil Fumarate Treatment for Chronic Hepatitis B
Heathcote, E. J., Marcellin, P., Buti, M., Gane, E., De Man, R. A., Krastev, Z., Germanidis, G., Lee, S. S., Flisiak, R., Kaita, K., et al. (2011) · Gastroenterology · doi:10.1053/j.gastro.2010.10.011 · Cited by 462
Alter, M. J. (1990) · JAMA · doi:10.1001/jama.263.9.1218 · Cited by 458
Murad, M. H., Montori, V. M., Ioannidis, J. P. A., Jaeschke, R., Devereaux, P. J., Prasad, K., Neumann, I., Carrasco-Labra, A., Agoritsas, T., Hatala, R., et al. (2014) · JAMA · doi:10.1001/jama.2014.5559 · Cited by 454
Self-citationXu, W. ‐., Cui, Y. ‐., Wang, L., Yang, H., Liang, Z. ‐., Li, X. ‐., Zhang, S. ‐., Qiao, F. ‐., Campbell, F., Chang, C. ‐., et al. (2009) · Journal of Viral Hepatitis · doi:10.1111/j.1365-2893.2008.01056.x · Cited by 387
Perinatal transmission of hepatitis B virus: an Australian experience
Wiseman, E., Fraser, M. A., Holden, S., Glass, A., Kidson, B. L., Heron, L. G., Maley, M. W., Ayres, A., LOCARNINI, S. A., & Levy, M. T. (2009) · The Medical Journal of Australia · doi:10.5694/j.1326-5377.2009.tb02524.x · Cited by 378
Zou, H., Chen, Y., Duan, Z., Zhang, H., & Pan, C. (2012) · Journal of Viral Hepatitis · doi:10.1111/j.1365-2893.2011.01492.x · Cited by 366
Han, G.-R., Cao, M.-K., Zhao, W., Jiang, H.-X., Wang, C.-M., Bai, S.-F., Yue, X., Wang, G.-J., Tang, X., & Fang, Z.-X. (2011) · Journal of Hepatology · doi:10.1016/j.jhep.2011.02.032 · Cited by 363
Lok, A. S. F., Lai, C.-L., Wu, P.-C., Leung, E. K. Y., & Lam, T.-S. (1987) · Gastroenterology · doi:10.1016/0016-5085(87)90613-5 · Cited by 326
Self-citationIncidence of Hepatitis B Virus Infections in Preschool Children in Taiwan
Beasley, R. P., Hwang, L.-Y., Lin, C.-C., Leu, M.-L., Stevens, C. E., Szmuness, W., & Chen, K.-P. (1982) · The Journal of Infectious Diseases · doi:10.1093/infdis/146.2.198 · Cited by 320
Stevens, C. E. (1985) · JAMA · doi:10.1001/jama.1985.03350360066020 · Cited by 256
Livingston, S. E., Simonetti, J. P., Bulkow, L. R., Homan, C. E., Snowball, M. M., Cagle, H. H., Negus, S. E., & McMahon, B. J. (2007) · Gastroenterology · doi:10.1053/j.gastro.2007.08.010 · Cited by 256
Self-citationChen, H., Lee, C., Chang, C., Ni, Y., Shyu, M., Chen, S., Hu, J., Lin, H. H., Zhao, L., Mu, S., et al. (2015) · Hepatology · doi:10.1002/hep.27837 · Cited by 255
Zhang, H., Pan, C. Q., Pang, Q., Tian, R., Yan, M., & Liu, X. (2014) · Hepatology · doi:10.1002/hep.27034 · Cited by 199
Schiff, E. R., Lee, S. S., Chao, Y., Kew Yoon, S., Bessone, F., Wu, S., Kryczka, W., Lurie, Y., Gadano, A., Kitis, G., et al. (2011) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2010.11.040 · Cited by 183
A longitudinal follow-up of asymptomatic hepatitis B surface antigen-positive chinese children
Lok, A. S. F., & Lai, C.-L. (1988) · Hepatology · doi:10.1002/hep.1840080527 · Cited by 177
Self-citationGreenup, A.-J., Tan, P. K., Nguyen, V., Glass, A., Davison, S., Chatterjee, U., Holdaway, S., Samarasinghe, D., Jackson, K., Locarnini, S. A., et al. (2014) · Journal of Hepatology · doi:10.1016/j.jhep.2014.04.038 · Cited by 167
Lamivudine in Late Pregnancy to Interrupt In Utero Transmission of Hepatitis B Virus
Shi, Z., Yang, Y., Ma, L., Li, X., & Schreiber, A. (2010) · Obstetrics and Gynecology · doi:10.1097/aog.0b013e3181e45951 · Cited by 156
Telbivudine Prevents Vertical Transmission From HBeAg-Positive Women With Chronic Hepatitis B
Pan, C. Q., Han, G., Jiang, H., Zhao, W., Cao, M., Wang, C., Yue, X., & Wang, G. (2012) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2012.01.019 · Cited by 152
Safety of tenofovir use during pregnancy
Siberry, G. K., Williams, P. L., Mendez, H. A., et al. (2012) · AIDS · doi:10.1097/qad.0b013e328352d135 · Cited by 139
A meta-analysis of lamivudine for interruption of mother-to-child transmission of hepatitis B virus
Han, L. (2011) · World Journal of Gastroenterology · doi:10.3748/wjg.v17.i38.4321 · Cited by 127
Siberry, G. K., Jacobson, D. L., Kalkwarf, H. J., Wu, J. W., DiMeglio, L. A., Yogev, R., Knapp, K. M., Wheeler, J., Butler, L., Hazra, R., et al. (2015) · Clinical Infectious Diseases · doi:10.1093/cid/civ437 · Cited by 125
Çelen, M. K. (2013) · World Journal of Gastroenterology · doi:10.3748/wjg.v19.i48.9377 · Cited by 90
Yu, M., Jiang, Q., Ji, Y., Wu, K.-H., Ju, L., Tang, X., & Yang, Y. (2014) · Journal of Clinical Virology · doi:10.1016/j.jcv.2014.06.005 · Cited by 30
Yu, M., Jiang, Q., Ji, Y., Jiang, H., Wu, K., Ju, L., Tang, X., & Wu, M. (2012) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-012-1557-2 · Cited by 26
Lu, Y.-P., Liang, X., Xiao, X., Huang, S., Liu, Z., Li, J., Hocher, B., & Chen, Y. (2014) · Clinical Laboratory · doi:10.7754/clin.lab.2013.130408 · Cited by 17
Cited by
Terrault, N. A., Lok, A. S. F., McMahon, B. J., Chang, K., Hwang, J. P., Jonas, M. M., Brown, R. S., Bzowej, N. H., & Wong, J. B. (2018) · Hepatology · doi:10.1002/hep.29800 · Cited by 4,306
Self-citationAASLD guidelines for treatment of chronic hepatitis B
Terrault, N. A., Bzowej, N. H., Chang, K., Hwang, J. P., Jonas, M. M., & Murad, M. H. (2016) · Hepatology · doi:10.1002/hep.28156 · Cited by 2,006
Self-citationApproved Antiviral Drugs over the Past 50 Years
De Clercq, E., & Li, G. (2016) · Clinical Microbiology Reviews · doi:10.1128/cmr.00102-15 · Cited by 1,430
Contemporary Epidemiology of Chronic Liver Disease and Cirrhosis
Moon, A. M., Singal, A. G., & Tapper, E. B. (2020) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2019.07.060 · Cited by 1,150
Schillie, S., Vellozzi, C., Reingold, A., Harris, A., Haber, P., Ward, J. W., & Nelson, N. P. (2018) · MMWR. Recommendations and Reports · doi:10.15585/mmwr.rr6701a1 · Cited by 815
Metadata
- Authors
- Brown, R. S., McMahon, B. J., Lok, A. S. F., Wong, J. B., Ahmed, A. T., Mouchli, M. A., Wang, Z., Prokop, L. J., Murad, M. H., & Mohammed, K.
- Venue
- Hepatology
- Published
- 2015-11-13
- Volume
- 63
- Issue
- 1
- Pages
- 319-333
- ISSN
- 0270-9139 (ISSN-L)
- 1527-3350
- OpenAlex
- W2173274566
- Cited by
- 324
- References
- 35
- FWCI
- 6.46
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.